Anti-Snoring Devices Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 10.60 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Anti-Snoring Devices Market Analysis
The anti-snoring market is expected to register a CAGR of 10.6% during the forecast period.
COVID-19 had a significant impact on the anti-snoring devices market owing to the high demand during the pandemic. Obstructive sleep apnea was reported to increase the risk of morbidity and mortality associated with COVID-19. For instance, as per a research article published in December 2021 by Cleveland Clinic, people with COVID-19 who experience sleep-disordered breathing had a 31% higher likelihood of hospitalization. Hence, the demand for CPAP devices was high among hospitalized COVID-19 patients. COVID-19 has a negligible impact on the studied market in the current scenario.
An increase in obesity and the geriatric population, increasing smoking and alcohol consumption, technological advancements in anti-snoring devices, and increased awareness among the people are the key factors responsible for the growth of the market. For instance, according to the World Population Review 2022 data, around 29.4% of the people in Canada were affected by obesity. Weight gain is a major contributor to the habit of snoring because the peculiarities in weight gain affect the elderly population. Thus, the high prevalence of obesity among people is expected to boost market growth over the forecast period.
Furthermore, an article published in Statpearls updated in August 2022 stated that in the United States, tonsillectomy was one of the most commonly performed surgical procedures. Over 500 thousand cases are performed annually in children less than 15 years of age. Sleep-disordered breathing (SDB) is one of the most common reasons for tonsillectomy. Therefore, the large number of procedures is estimated to boost the demand for anti-snoring devices, such as tongue-retaining devices, which are required for the treatment of such diseases, thereby propelling the market growth during the forecast period.
Additionally, technological advancements and new product launches by market players are expected to propel market growth during the forecast period. For instance, in October 2021, Superior Sensor Technology launched a new dual low-pressure sensor product series for continuous PAP (CPAP), bi-level PAP (BiPAP), and automatic PAP (APAP) products used for sleep apnoea and other breathing sleep disorders. Therefore, owing to the factors such as the high burden of obesity, sleep disorders, and rising product approvals and launches by market players, the studied market is anticipated to witness growth over the analysis period. However, the high cost associated with custom-made oral devices and the social stigma associated with snoring are expected to restrain the market growth during the forecast period.
Anti-Snoring Devices Market Trends
The Continuous Positive Airway Pressure (CPAP) Devices Sub-segment is Expected to Hold a Significant Market Share Over The Forecast Period
CPAP stands for continuous positive airway pressure. A CPAP device is a machine that uses mild air pressure to keep breathing airways open while a person is asleep. CPAP is an effective treatment for moderate to severe obstructive sleep apnea. CPAP machine includes a mask that fits over the nose or nose and mouth, straps to position the mask, a tube that connects the mask to the machine's motor, and a motor that blows air into the tube.
The development of new products, approvals, and launches indicates the high demand for CPAP devices in developing countries, which is propelling the growth of the market segment. For instance, in June 2021, the Indian Institute of Technology, Ropar, developed a device named 'Jivan Vayu,' which can be used as a substitute for a CPAP machine. This is the nation's one of the first such devices that functions even without electricity and is adapted to oxygen generation units like O2 cylinders and oxygen pipelines in hospitals. These provisions are not available in otherwise existing CPAP machines. Such development of advanced products in developing countries is also augmenting the market segment's growth.
Furthermore, in April 2021, Philips Respironics launched a new and improved auto CPAP machine named DreamStation 2 CPAP in the United States. The development of the Advanced DreamStation 2 has refined the overall auto CPAP machine into a lighter, more compact unit. The device is completely redesigned with a focus on enhancing CPAP therapy for patients. Additionally, in August 2021, ResMed launched AirSense 11, the company's next-generation CPAP device, designed to treat and manage obstructive sleep apnea. AirSense 11 includes new features like a personal therapy assistant and care check-in designed to provide tailored guidance to CPAP users, helping ease them into therapy and comfortable nightly use.
Therefore, owing to the launches of technologically advanced CPAP Devices and the high burden of sleep disorders, the segment is expected to witness significant growth during the forecast period.
North America is Expected to Dominate the Market During the Forecast Period
North America is expected to dominate the market owing to factors such as the high incidence of sleep diseases, high research and development (R&D) spending, product launches, and approvals, along with the high concentration of market players in the region.
For instance, according to the Centers for Disease Control and Prevention, Sleep and Sleep Disorders statistics, updated in November 2022, the age-adjusted prevalence of short sleep duration in the United States was 34% in females and 35.8% in males. Additionally, the article published in the American Journal of Respiratory and Critical Care Medicine in December 2021 reported that the global prevalence of obstructive sleep apnea was 22.6% last year. Such a high burden of obstructive sleep apnea creates a need for CPAP devices and thus drives the growth of the market segment.
Furthermore, according to the National Institute of Health, Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC), May 2022 update, the spending on R&D in the United States for sleep research was USD 493 million last year and USD 515 million this year. The grant provided by the government for sleep research is expected to create opportunities for market players to develop innovative devices for the management and treatment of such diseases, which is further expected to propel market growth in the upcoming years.
Additionally, the rising product launches in the region are also contributing significantly to market growth. For instance, in February 2021, the United States Food and Drug Administration (US FDA) approved the commercialization of a prescription-only anti-snoring device, 'eXciteOSA,' developed by Rotech Healthcare. It delivers electrical muscle stimulation via a mouthpiece that is placed around the tongue. Therefore, owing to the above-mentioned factors, such as the high burden of sleep disorders, rising R&D spending, and product approvals and launches by market players, the growth of the studied market is anticipated in the North American Region.
Anti-Snoring Devices Industry Overview
The anti-snoring market is fragmented in nature due to the presence of several major players. The competitive landscape includes an analysis of a few international as well as local companies which hold major or significant market shares. Some of the key players include Fisher & Paykel Healthcare Limited, Koninklijke Philips NV, ResMed, ASF Medical GmbH (Tomed GmbH), and Apnea Sciences.
Anti-Snoring Devices Market Leaders
-
Fisher & Paykel Healthcare Limited
-
Koninklijke Philips NV
-
Resmed
-
ASF Medical GmbH (Tomed GmbH)
-
Apnea Sciences
*Disclaimer: Major Players sorted in no particular order
Anti-Snoring Devices Market News
- Jul 2022: Glidewell launched a new addition to its portfolio of mandibular advancement devices, the Silent Nite Sleep Appliance with Glidewell Hinge. The device is used to treat snoring and obstructive sleep apnea (OSA).
- Jun 2022: Illusion Aligners launched a new oral Anti-Snoring Device (ASD). The device is easy to wear, effective, and comfortable for people to use.
Anti-Snoring Devices Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increase in Obesity and Geriatric Population
- 4.2.2 Increasing Smoking and Alcohol Consumption
- 4.2.3 Technological Advancements in Anti-Snoring Devices
-
4.3 Market Restraints
- 4.3.1 High Costs of Custom-made Oral Devices
- 4.3.2 Poor Efficacy and Lack of Scientific Validation of the Anti-snoring Devices
- 4.3.3 Social Stigma Associated with Snoring
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Device Type
- 5.1.1 Mandibular Advancement Devices (MAD)
- 5.1.2 Tongue Stabilizing Devices (TSD)
- 5.1.3 Continuous Positive Airway Pressure (CPAP) Devices
- 5.1.4 Other Device Types
-
5.2 By Surgical Procedure
- 5.2.1 Uvulopalatopharyngoplasty (UPPP)
- 5.2.2 Somnoplasty
- 5.2.3 Pillar Procedure
- 5.2.4 Tonsillectomy
- 5.2.5 Radiofrequency Palatoplasty
- 5.2.6 Other Surgical Procedures
-
5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Apnea Sciences
- 6.1.2 ASF Medical GmbH (Tomed GmbH)
- 6.1.3 Fisher & Paykel Healthcare Limited
- 6.1.4 Koninklijke Philips NV
- 6.1.5 Lear Corporation (AccuMED Corp.)
- 6.1.6 Meditas
- 6.1.7 Mitsui Chemicals (Whole You Inc.)
- 6.1.8 ResMed
- 6.1.9 SomnoMed
- 6.1.10 The Pure Sleep Company
- 6.1.11 Innovative Health Technologies
- 6.1.12 GSK Plc
- 6.1.13 Rotech Healthcare
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityAnti-Snoring Devices Industry Segmentation
As per the scope of this report, anti-snoring treatment devices are defined as the equipment used to prevent snoring.
The Anti-Snoring Treatment Market is Segmented by Device Type (Mandibular Advancement Devices (MAD), Tongue Stabilizing Devices (TSD), Continuous Positive Airway Pressure (CPAP) Devices, and Other Device Types), Surgical Procedure (Uvulopalatopharyngoplasty (UPPP), Somnoplasty, Pillar Procedure, Tonsillectomy, Radiofrequency Palatoplasty, and Other Surgical Procedures), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.
| By Device Type | Mandibular Advancement Devices (MAD) | |
| Tongue Stabilizing Devices (TSD) | ||
| Continuous Positive Airway Pressure (CPAP) Devices | ||
| Other Device Types | ||
| By Surgical Procedure | Uvulopalatopharyngoplasty (UPPP) | |
| Somnoplasty | ||
| Pillar Procedure | ||
| Tonsillectomy | ||
| Radiofrequency Palatoplasty | ||
| Other Surgical Procedures | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Anti-Snoring Devices Market Research FAQs
What is the current Anti-Snoring Market size?
The Anti-Snoring Market is projected to register a CAGR of 10.60% during the forecast period (2024-2029)
Who are the key players in Anti-Snoring Market?
Fisher & Paykel Healthcare Limited, Koninklijke Philips NV, Resmed, ASF Medical GmbH (Tomed GmbH) and Apnea Sciences are the major companies operating in the Anti-Snoring Market.
Which is the fastest growing region in Anti-Snoring Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Anti-Snoring Market?
In 2024, the North America accounts for the largest market share in Anti-Snoring Market.
What years does this Anti-Snoring Market cover?
The report covers the Anti-Snoring Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Anti-Snoring Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Cyber Security Software Industry Report
Statistics for the 2024 Cyber Security Software market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Cyber Security Software analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
